Could You or a Loved One be Deemed “too expensive” to Treat?

As federal policymakers search for methods to address drug prices here in the United States, some are championing approaches used in other countries. Many countries, including Canada and the U.K., use a calculation called “quality-adjusted life year (QALY)” to determine what treatment or therapy a patient receives. Sue Peschin, president and CEO of the Alliance for Aging Research and Duane Schulthess, managing director of Vital Transformation offer insight into how QALY harms medically complex, vulnerable patients.

When a government bureaucrat driven by cost containment goals, instead of a patient’s own physician, makes treatment decisions, patients suffer. Patients and Providers United amplifies the voices that seek to keep patients and providers – not bureaucratic middlemen – at the center of medical decision making by telling policymakers Don’t Complicate My Care!